## **Core Concept**
The question tests knowledge of anticoagulant medications, specifically direct thrombin inhibitors (DTIs) that are administered orally. Direct thrombin inhibitors are a class of anticoagulants that directly inhibit thrombin, a key enzyme in the coagulation cascade.

## **Why the Correct Answer is Right**
Dabigatran is an orally administered direct thrombin inhibitor used to prevent stroke in patients with non-valvular atrial fibrillation and to treat deep vein thrombosis and pulmonary embolism. It works by selectively and reversibly inhibiting thrombin. This mechanism prevents fibrin formation and thrombus development.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Argatroban is a direct thrombin inhibitor but it is administered intravenously, not orally. It is used as an anticoagulant in patients with heparin-induced thrombocytopenia.
- **Option B:** Ximelagatran was an oral direct thrombin inhibitor but it was withdrawn from the market in several countries due to liver toxicity concerns. It is not commonly used or recommended anymore.
- **Option C:** There are no well-known, commonly used oral direct thrombin inhibitors listed here aside from Dabigatran.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that while Dabigatran is an oral DTI, its use requires careful consideration of renal function since it is primarily excreted by the kidneys. Monitoring renal function is crucial before and during treatment with Dabigatran.

## **Correct Answer:** . Dabigatran.